纳米粒子方法用于肝炎治疗和临床翻译
Nura Adam Mohamed1, Farah Atifi2, Zineb Ourradi2
1Medical and Health Sciences Office, QU-Health, Qatar University, Doha, Qatar.
Discover nano
|February 6, 2026
概括
纳米技术通过改善药物输送和向来增强B型肝炎 (HBV) 和C型肝炎 (HCV) 治疗. 进一步的研究和合作对于这些先进的抗病毒疗法的临床转化至关重要.
科学领域:
- 乙型肝炎和C型肝炎病毒 (HBV和HCV) 治疗药物
- 纳米医学用于传染病.
- 开发抗病毒药物的开发.
背景情况:
- 乙型肝炎病毒和型肝炎病毒是全球重要的健康问题,导致肝脏疾病和死亡率.
- 目前的直接作用抗病毒药物 (DAA) 有其局限性,包括针对性差和耐药性.
- 纳米技术为克服这些局限性提供了潜在的解决方案.
研究的目的:
- 审查基于纳米粒子 (NP) 的HBV和HCV治疗策略的最新进展.
- 探索NP设计,交付平台和翻译应用.
- 突出人工智能在针对病毒性肝炎的纳米医学个性化方面的作用.
主要方法:
- 检查各种纳米载体类型 (基于脂质,聚合物,金属,仿生).
- 针对性传递策略的分析 (例如,银河糖介导吸收,pH响应释放).
- 审查临床前研究和人工智能驱动的设计框架.
主要成果:
- 纳米粒子在药物输送,基因编辑和针对HBV和HCV的疫苗开发方面表现有前景.
- 有针对性的策略可以改善药物局部化,降低毒性.
- 临床前研究表明,基于NP的疗法具有显著的抗病毒作用.
结论:
- 针对HBV和HCV的纳米药物的临床翻译受到免疫性和制造等挑战的阻碍.
- 临床实施需要跨学科的合作和标准化的评估.
- 纳米技术与人工智能和基因编辑的整合可以彻底改变HBV和HCV的管理.
相关概念视频
Translation
157.1K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.1K
Translation
17.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.9K
Initiation of Translation
39.1K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.1K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Termination of Translation
27.8K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.8K
Improving Translational Accuracy
15.0K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.0K


